<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1989-07-01" modified="2020-10-07" version="188">
<accession>P10914</accession>
<accession>Q96GG7</accession>
<name>IRF1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Interferon regulatory factor 1</fullName>
<shortName>IRF-1</shortName>
</recommendedName>
</protein>
<gene>
<name type="primary">IRF1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1989" name="Nucleic Acids Res." volume="17" first="3292" last="3292">
<title>Sequence of a cDNA coding for human IRF-1.</title>
<authorList>
<person name="Maruyama M."/>
<person name="Fujita T."/>
<person name="Taniguchi T."/>
</authorList>
<dbReference type="PubMed" id="2726461"/>
<dbReference type="DOI" id="10.1093/nar/17.8.3292"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1988" name="Cell" volume="54" first="903" last="913">
<title>Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements.</title>
<authorList>
<person name="Miyamoto M."/>
<person name="Fujita T."/>
<person name="Kimura Y."/>
<person name="Maruyama M."/>
<person name="Harada H."/>
<person name="Sudo Y."/>
<person name="Miyata T."/>
<person name="Taniguchi T."/>
</authorList>
<dbReference type="PubMed" id="3409321"/>
<dbReference type="DOI" id="10.1016/s0092-8674(88)91307-4"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1992" name="DNA Cell Biol." volume="11" first="605" last="611">
<title>Human interferon regulatory factor 1: intron-exon organization.</title>
<authorList>
<person name="Cha Y."/>
<person name="Sims S.H."/>
<person name="Romine M.F."/>
<person name="Kaufmann M."/>
<person name="Deisseroth A.B."/>
</authorList>
<dbReference type="PubMed" id="1382447"/>
<dbReference type="DOI" id="10.1089/dna.1992.11.605"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Pancreas</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1993" name="Science" volume="259" first="968" last="971">
<title>Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.</title>
<authorList>
<person name="Willman C.L."/>
<person name="Sever C.E."/>
<person name="Pallavicini M.G."/>
<person name="Harada H."/>
<person name="Tanaka N."/>
<person name="Slovak M.L."/>
<person name="Yamamoto H."/>
<person name="Harada K."/>
<person name="Meeker T.C."/>
<person name="List A.F."/>
<person name="Taniguchi T."/>
</authorList>
<dbReference type="PubMed" id="8438156"/>
<dbReference type="DOI" id="10.1126/science.8438156"/>
</citation>
<scope>INVOLVEMENT IN LEUKEMIAS</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1999" name="Mol. Cell. Biochem." volume="191" first="169" last="180">
<title>A role for casein kinase II phosphorylation in the regulation of IRF-1 transcriptional activity.</title>
<authorList>
<person name="Lin R."/>
<person name="Hiscott J."/>
</authorList>
<dbReference type="PubMed" id="10094406"/>
<dbReference type="DOI" id="10.1023/a:1006850009017"/>
</citation>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2001" name="Annu. Rev. Immunol." volume="19" first="623" last="655">
<title>IRF family of transcription factors as regulators of host defense.</title>
<authorList>
<person name="Taniguchi T."/>
<person name="Ogasawara K."/>
<person name="Takaoka A."/>
<person name="Tanaka N."/>
</authorList>
<dbReference type="PubMed" id="11244049"/>
<dbReference type="DOI" id="10.1146/annurev.immunol.19.1.623"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2002" name="J. Interferon Cytokine Res." volume="22" first="5" last="14">
<title>Activities of IRF-1.</title>
<authorList>
<person name="Kroeger A."/>
<person name="Koester M."/>
<person name="Schroeder K."/>
<person name="Hauser H."/>
<person name="Mueller P.P."/>
</authorList>
<dbReference type="PubMed" id="11846971"/>
<dbReference type="DOI" id="10.1089/107999002753452610"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2002" name="J. Interferon Cytokine Res." volume="22" first="39" last="47">
<title>IRF-1 as a negative regulator of cell proliferation.</title>
<authorList>
<person name="Romeo G."/>
<person name="Fiorucci G."/>
<person name="Chiantore M.V."/>
<person name="Percario Z.A."/>
<person name="Vannucchi S."/>
<person name="Affabris E."/>
</authorList>
<dbReference type="PubMed" id="11846974"/>
<dbReference type="DOI" id="10.1089/107999002753452647"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="6298" last="6310">
<title>Interferon regulatory factor 1 (IRF-1) and IRF-2 distinctively up-regulate gene expression and production of interleukin-7 in human intestinal epithelial cells.</title>
<authorList>
<person name="Oshima S."/>
<person name="Nakamura T."/>
<person name="Namiki S."/>
<person name="Okada E."/>
<person name="Tsuchiya K."/>
<person name="Okamoto R."/>
<person name="Yamazaki M."/>
<person name="Yokota T."/>
<person name="Aida M."/>
<person name="Yamaguchi Y."/>
<person name="Kanai T."/>
<person name="Handa H."/>
<person name="Watanabe M."/>
</authorList>
<dbReference type="PubMed" id="15226432"/>
<dbReference type="DOI" id="10.1128/mcb.24.14.6298-6310.2004"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION BY IFN</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="10083" last="10098">
<title>Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53.</title>
<authorList>
<person name="Dornan D."/>
<person name="Eckert M."/>
<person name="Wallace M."/>
<person name="Shimizu H."/>
<person name="Ramsay E."/>
<person name="Hupp T.R."/>
<person name="Ball K.L."/>
</authorList>
<dbReference type="PubMed" id="15509808"/>
<dbReference type="DOI" id="10.1128/mcb.24.22.10083-10098.2004"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH EP300</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Nat. Rev. Immunol." volume="6" first="644" last="658">
<title>IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.</title>
<authorList>
<person name="Honda K."/>
<person name="Taniguchi T."/>
</authorList>
<dbReference type="PubMed" id="16932750"/>
<dbReference type="DOI" id="10.1038/nri1900"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2007" name="J. Cell. Physiol." volume="213" first="502" last="510">
<title>Central role of interferon regulatory factor-1 (IRF-1) in controlling retinoic acid inducible gene-I (RIG-I) expression.</title>
<authorList>
<person name="Su Z.Z."/>
<person name="Sarkar D."/>
<person name="Emdad L."/>
<person name="Barral P.M."/>
<person name="Fisher P.B."/>
</authorList>
<dbReference type="PubMed" id="17516545"/>
<dbReference type="DOI" id="10.1002/jcp.21128"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION BY IFN</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2007" name="Neoplasia" volume="9" first="1012" last="1020">
<title>RNA interference of interferon regulatory factor-1 gene expression in THP-1 cell line leads to Toll-like receptor-4 overexpression/activation as well as up-modulation of annexin-II.</title>
<authorList>
<person name="Maratheftis C.I."/>
<person name="Giannouli S."/>
<person name="Spachidou M.P."/>
<person name="Panayotou G."/>
<person name="Voulgarelis M."/>
</authorList>
<dbReference type="PubMed" id="18084608"/>
<dbReference type="DOI" id="10.1593/neo.07640"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="17028" last="17033">
<title>Elevated level of SUMOylated IRF-1 in tumor cells interferes with IRF-1-mediated apoptosis.</title>
<authorList>
<person name="Park J."/>
<person name="Kim K."/>
<person name="Lee E.-J."/>
<person name="Seo Y.-J."/>
<person name="Lim S.-N."/>
<person name="Park K."/>
<person name="Rho S.B."/>
<person name="Lee S.-H."/>
<person name="Lee J.-H."/>
</authorList>
<dbReference type="PubMed" id="17942705"/>
<dbReference type="DOI" id="10.1073/pnas.0609852104"/>
</citation>
<scope>SUMOYLATION AT LYS-275 AND LYS-299</scope>
<scope>UBIQUITINATION AT LYS-275 AND LYS-299</scope>
<scope>FUNCTION</scope>
<scope>INDUCTION BY IFN</scope>
<scope>MUTAGENESIS OF LYS-275 AND LYS-299</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Adv. Exp. Med. Biol." volume="617" first="367" last="374">
<title>IRF-1 promotes apoptosis in p53-damaged basal-type human mammary epithelial cells: a model for early basal-type mammary carcinogenesis.</title>
<authorList>
<person name="Bowie M.L."/>
<person name="Ibarra C."/>
<person name="Seewalt V.L."/>
</authorList>
<dbReference type="PubMed" id="18497060"/>
<dbReference type="DOI" id="10.1007/978-0-387-69080-3_35"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="J. Immunol." volume="181" first="1673" last="1682">
<title>IFN regulatory factor-1 negatively regulates CD4+ CD25+ regulatory T cell differentiation by repressing Foxp3 expression.</title>
<authorList>
<person name="Fragale A."/>
<person name="Gabriele L."/>
<person name="Stellacci E."/>
<person name="Borghi P."/>
<person name="Perrotti E."/>
<person name="Ilari R."/>
<person name="Lanciotti A."/>
<person name="Remoli A.L."/>
<person name="Venditti M."/>
<person name="Belardelli F."/>
<person name="Battistini A."/>
</authorList>
<dbReference type="PubMed" id="18641303"/>
<dbReference type="DOI" id="10.4049/jimmunol.181.3.1673"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="PLoS ONE" volume="4" first="E5397" last="E5397">
<title>Type I interferons and interferon regulatory factors regulate TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected macrophages.</title>
<authorList>
<person name="Huang Y."/>
<person name="Walstrom A."/>
<person name="Zhang L."/>
<person name="Zhao Y."/>
<person name="Cui M."/>
<person name="Ye L."/>
<person name="Zheng J.C."/>
</authorList>
<dbReference type="PubMed" id="19404407"/>
<dbReference type="DOI" id="10.1371/journal.pone.0005397"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION BY HIV AND IFN</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2010" name="Cancer Immunol. Immunother." volume="59" first="489" last="510">
<title>Regulation of immunity and oncogenesis by the IRF transcription factor family.</title>
<authorList>
<person name="Savitsky D."/>
<person name="Tamura T."/>
<person name="Yanai H."/>
<person name="Taniguchi T."/>
</authorList>
<dbReference type="PubMed" id="20049431"/>
<dbReference type="DOI" id="10.1007/s00262-009-0804-6"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="Cell Death Differ." volume="17" first="699" last="709">
<title>IRF-1 transcriptionally upregulates PUMA, which mediates the mitochondrial apoptotic pathway in IRF-1-induced apoptosis in cancer cells.</title>
<authorList>
<person name="Gao J."/>
<person name="Senthil M."/>
<person name="Ren B."/>
<person name="Yan J."/>
<person name="Xing Q."/>
<person name="Yu J."/>
<person name="Zhang L."/>
<person name="Yim J.H."/>
</authorList>
<dbReference type="PubMed" id="19851330"/>
<dbReference type="DOI" id="10.1038/cdd.2009.156"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION BY IFN</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="J. Virol." volume="85" first="5070" last="5080">
<title>Human papillomavirus type 16 E5 protein induces expression of beta interferon through interferon regulatory factor 1 in human keratinocytes.</title>
<authorList>
<person name="Muto V."/>
<person name="Stellacci E."/>
<person name="Lamberti A.G."/>
<person name="Perrotti E."/>
<person name="Carrabba A."/>
<person name="Matera G."/>
<person name="Sgarbanti M."/>
<person name="Battistini A."/>
<person name="Liberto M.C."/>
<person name="Foca A."/>
</authorList>
<dbReference type="PubMed" id="21389130"/>
<dbReference type="DOI" id="10.1128/jvi.02114-10"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION BY HPV16 E5</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2012" name="Cancer Lett." volume="319" first="56" last="65">
<title>Interferon regulatory factor 1 (IRF-1) induces p21(WAF1/CIP1) dependent cell cycle arrest and p21(WAF1/CIP1) independent modulation of survivin in cancer cells.</title>
<authorList>
<person name="Armstrong M.J."/>
<person name="Stang M.T."/>
<person name="Liu Y."/>
<person name="Gao J."/>
<person name="Ren B."/>
<person name="Zuckerbraun B.S."/>
<person name="Mahidhara R.S."/>
<person name="Xing Q."/>
<person name="Pizzoferrato E."/>
<person name="Yim J.H."/>
</authorList>
<dbReference type="PubMed" id="22200613"/>
<dbReference type="DOI" id="10.1016/j.canlet.2011.12.027"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="12622" last="12633">
<title>Interferon regulatory factor 1 transactivates the expression of human DNA polymerase eta in response to the carcinogen N-methyl-N'-nitro-N-nitrosoguanidine.</title>
<authorList>
<person name="Qi H."/>
<person name="Zhu H."/>
<person name="Lou M."/>
<person name="Fan Y."/>
<person name="Liu H."/>
<person name="Shen J."/>
<person name="Li Z."/>
<person name="Lv X."/>
<person name="Shan J."/>
<person name="Zhu L."/>
<person name="Chin Y.E."/>
<person name="Shao J."/>
</authorList>
<dbReference type="PubMed" id="22367195"/>
<dbReference type="DOI" id="10.1074/jbc.m111.313429"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION BY N-METHYL-N'-NITRO-N-NITROSOGUANIDINE</scope>
<scope>ACETYLATION AT LYS-78</scope>
<scope>MUTAGENESIS OF LYS-78</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2020" name="Proc. Natl. Acad. Sci. U.S.A." volume="117" first="11471" last="11482">
<title>ZBED2 is an antagonist of interferon regulatory factor 1 and modifies cell identity in pancreatic cancer.</title>
<authorList>
<person name="Somerville T.D.D."/>
<person name="Xu Y."/>
<person name="Wu X.S."/>
<person name="Maia-Silva D."/>
<person name="Hur S.K."/>
<person name="de Almeida L.M.N."/>
<person name="Preall J.B."/>
<person name="Koo P.K."/>
<person name="Vakoc C.R."/>
</authorList>
<dbReference type="PubMed" id="32385160"/>
<dbReference type="DOI" id="10.1073/pnas.1921484117"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1998" name="Int. J. Cancer" volume="77" first="522" last="527">
<title>Functionally inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancer.</title>
<authorList>
<person name="Nozawa H."/>
<person name="Oda E."/>
<person name="Ueda S."/>
<person name="Tamura G."/>
<person name="Maesawa C."/>
<person name="Muto T."/>
<person name="Taniguchi T."/>
<person name="Tanaka N."/>
</authorList>
<dbReference type="PubMed" id="9679752"/>
<dbReference type="DOI" id="10.1002/(sici)1097-0215(19980812)77:4&lt;522::aid-ijc8&gt;3.0.co;2-w"/>
</citation>
<scope>VARIANT GASC LEU-8</scope>
<scope>CHARACTERIZATION OF VARIANT GASC LEU-8</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1999" name="Biochim. Biophys. Acta" volume="1446" first="140" last="144">
<title>Interferon regulatory factor 1 tryptophan 11 to arginine point mutation abolishes DNA binding.</title>
<authorList>
<person name="Eason D.D."/>
<person name="Shepherd A.T."/>
<person name="Blanck G."/>
</authorList>
<dbReference type="PubMed" id="10395927"/>
<dbReference type="DOI" id="10.1016/s0167-4781(99)00078-0"/>
</citation>
<scope>VARIANT GASC ARG-11</scope>
</reference>
<comment type="function">
<text evidence="5 6 7 8 9 10 11 12 13 14 15 16 17 19 20 21 22 23">Transcriptional regulator which displays a remarkable functional diversity in the regulation of cellular responses (PubMed:15226432, PubMed:15509808, PubMed:17516545, PubMed:17942705, PubMed:18497060, PubMed:19404407, PubMed:19851330, PubMed:22367195, PubMed:32385160). Regulates transcription of IFN and IFN-inducible genes, host response to viral and bacterial infections, regulation of many genes expressed during hematopoiesis, inflammation, immune responses and cell proliferation and differentiation, regulation of the cell cycle and induction of growth arrest and programmed cell death following DNA damage (PubMed:15226432, PubMed:15509808, PubMed:17516545, PubMed:17942705, PubMed:18497060, PubMed:19404407, PubMed:19851330, PubMed:22367195). Stimulates both innate and acquired immune responses through the activation of specific target genes and can act as a transcriptional activator and repressor regulating target genes by binding to an interferon-stimulated response element (ISRE) in their promoters (PubMed:15226432, PubMed:15509808, PubMed:17516545, PubMed:17942705, PubMed:18497060, PubMed:19404407, PubMed:19851330, PubMed:21389130, PubMed:22367195). Competes with the transcriptional repressor ZBED2 for binding to a common consensus sequence in gene promoters (PubMed:32385160). Its target genes for transcriptional activation activity include: genes involved in anti-viral response, such as IFN-alpha/beta, DDX58/RIG-I, TNFSF10/TRAIL, ZBP1, OAS1/2, PIAS1/GBP, EIF2AK2/PKR and RSAD2/viperin; antibacterial response, such as NOS2/INOS; anti-proliferative response, such as p53/TP53, LOX and CDKN1A; apoptosis, such as BBC3/PUMA, CASP1, CASP7 and CASP8; immune response, such as IL7, IL12A/B and IL15, PTGS2/COX2 and CYBB; DNA damage responses and DNA repair, such as POLQ/POLH; MHC class I expression, such as TAP1, PSMB9/LMP2, PSME1/PA28A, PSME2/PA28B and B2M and MHC class II expression, such as CIITA; metabolic enzymes, such as ACOD1/IRG1 (PubMed:15226432, PubMed:15509808, PubMed:17516545, PubMed:17942705, PubMed:18497060, PubMed:19404407, PubMed:19851330, PubMed:22367195). Represses genes involved in anti-proliferative response, such as BIRC5/survivin, CCNB1, CCNE1, CDK1, CDK2 and CDK4 and in immune response, such as FOXP3, IL4, ANXA2 and TLR4 (PubMed:18641303, PubMed:22200613). Stimulates p53/TP53-dependent transcription through enhanced recruitment of EP300 leading to increased acetylation of p53/TP53 (PubMed:15509808, PubMed:18084608). Plays an important role in immune response directly affecting NK maturation and activity, macrophage production of IL12, Th1 development and maturation of CD8+ T-cells (PubMed:11244049, PubMed:11846971, PubMed:11846974, PubMed:16932750). Also implicated in the differentiation and maturation of dendritic cells and in the suppression of regulatory T (Treg) cells development (PubMed:11244049, PubMed:11846971, PubMed:11846974, PubMed:16932750). Acts as a tumor suppressor and plays a role not only in antagonism of tumor cell growth but also in stimulating an immune response against tumor cells (PubMed:20049431).</text>
</comment>
<comment type="activity regulation">
<text evidence="1">Activated by MYD88.</text>
</comment>
<comment type="subunit">
<text evidence="1 6">Monomer (By similarity). Homodimer (By similarity). Interacts with EP300 (PubMed:15509808). Interacts with MYD88 (By similarity). Interacts with PIAS3 (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1055781">
<id>P10914</id>
</interactant>
<interactant intactId="EBI-80140">
<id>P63165</id>
<label>SUMO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1055781">
<id>P10914</id>
</interactant>
<interactant intactId="EBI-866453">
<id>P03129</id>
<label>E7</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="1">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="1">Cytoplasm</location>
</subcellularLocation>
<text evidence="1">MYD88-associated IRF1 migrates into the nucleus more efficiently than non-MYD88-associated IRF1.</text>
</comment>
<comment type="induction">
<text evidence="5 7 8 12 13 14 16 17">Induced by HPV16 E5 (PubMed:21389130). Induced by HIV (PubMed:19404407). By interferon (IFN) (PubMed:15226432, PubMed:17516545, PubMed:17942705, PubMed:19404407, PubMed:19851330, PubMed:32385160). Induced by N-methyl-N'-nitro-N-nitrosoguanidine (PubMed:22367195).</text>
</comment>
<comment type="PTM">
<text evidence="3">Phosphorylated by CK2 and this positively regulates its activity.</text>
</comment>
<comment type="PTM">
<text evidence="1 8">Sumoylation represses the transcriptional activity and displays enhanced resistance to protein degradation (PubMed:17942705). Sumolyated by UBE2I/UBC9 and SUMO1 (By similarity). Inactivates the tumor suppressor activity (PubMed:17942705). Elevated levels in tumor cells (PubMed:17942705). Major site is Lys-275 (PubMed:17942705). Sumoylation is enhanced by PIAS3 (By similarity). Desumoylated by SENP1 in tumor cells and appears to compete with ubiquitination on C-terminal sites (PubMed:17942705).</text>
</comment>
<comment type="PTM">
<text evidence="8">Ubiquitinated. Appears to compete with sumoylation on C-terminal sites.</text>
</comment>
<comment type="disease" evidence="4 18">
<disease id="DI-02971">
<name>Gastric cancer</name>
<acronym>GASC</acronym>
<description>A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease.</description>
<dbReference type="MIM" id="613659"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>Deletion or rearrangement of IRF1 are found in preleukemic myelodysplastic syndrome (MDS) and acute myelogenous leukemia (AML).</text>
</comment>
<comment type="similarity">
<text evidence="2">Belongs to the IRF family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/IRF1ID40990ch5q23.html"/>
</comment>
<dbReference type="EMBL" id="X14454">
<property type="protein sequence ID" value="CAA32624.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L05072">
<property type="protein sequence ID" value="AAA36043.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BT019756">
<property type="protein sequence ID" value="AAV38561.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC009483">
<property type="protein sequence ID" value="AAH09483.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4155.1"/>
<dbReference type="PIR" id="B31595">
<property type="entry name" value="B31595"/>
</dbReference>
<dbReference type="PIR" id="I52998">
<property type="entry name" value="I52998"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002189.1">
<property type="nucleotide sequence ID" value="NM_002198.2"/>
</dbReference>
<dbReference type="BioGRID" id="109867">
<property type="interactions" value="40"/>
</dbReference>
<dbReference type="DIP" id="DIP-40988N"/>
<dbReference type="IntAct" id="P10914">
<property type="interactions" value="6"/>
</dbReference>
<dbReference type="MINT" id="P10914"/>
<dbReference type="STRING" id="9606.ENSP00000245414"/>
<dbReference type="iPTMnet" id="P10914"/>
<dbReference type="PhosphoSitePlus" id="P10914"/>
<dbReference type="BioMuta" id="IRF1"/>
<dbReference type="DMDM" id="20178295"/>
<dbReference type="EPD" id="P10914"/>
<dbReference type="jPOST" id="P10914"/>
<dbReference type="MassIVE" id="P10914"/>
<dbReference type="PaxDb" id="P10914"/>
<dbReference type="PeptideAtlas" id="P10914"/>
<dbReference type="PRIDE" id="P10914"/>
<dbReference type="ProteomicsDB" id="52676"/>
<dbReference type="Antibodypedia" id="3180">
<property type="antibodies" value="466 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="3659"/>
<dbReference type="Ensembl" id="ENST00000245414">
<property type="protein sequence ID" value="ENSP00000245414"/>
<property type="gene ID" value="ENSG00000125347"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000405885">
<property type="protein sequence ID" value="ENSP00000384406"/>
<property type="gene ID" value="ENSG00000125347"/>
</dbReference>
<dbReference type="GeneID" id="3659"/>
<dbReference type="KEGG" id="hsa:3659"/>
<dbReference type="CTD" id="3659"/>
<dbReference type="DisGeNET" id="3659"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000125347.13"/>
<dbReference type="GeneCards" id="IRF1"/>
<dbReference type="HGNC" id="HGNC:6116">
<property type="gene designation" value="IRF1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000125347">
<property type="expression patterns" value="Tissue enhanced (blood)"/>
</dbReference>
<dbReference type="MalaCards" id="IRF1"/>
<dbReference type="MIM" id="147575">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="613659">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P10914"/>
<dbReference type="OpenTargets" id="ENSG00000125347"/>
<dbReference type="PharmGKB" id="PA29915"/>
<dbReference type="eggNOG" id="ENOG502QVVN">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000156288"/>
<dbReference type="HOGENOM" id="CLU_056386_1_0_1"/>
<dbReference type="InParanoid" id="P10914"/>
<dbReference type="KO" id="K09444"/>
<dbReference type="OMA" id="WINKDKM"/>
<dbReference type="OrthoDB" id="734108at2759"/>
<dbReference type="PhylomeDB" id="P10914"/>
<dbReference type="TreeFam" id="TF328512"/>
<dbReference type="PathwayCommons" id="P10914"/>
<dbReference type="Reactome" id="R-HSA-877300">
<property type="pathway name" value="Interferon gamma signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-909733">
<property type="pathway name" value="Interferon alpha/beta signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-983231">
<property type="pathway name" value="Factors involved in megakaryocyte development and platelet production"/>
</dbReference>
<dbReference type="SignaLink" id="P10914"/>
<dbReference type="SIGNOR" id="P10914"/>
<dbReference type="BioGRID-ORCS" id="3659">
<property type="hits" value="12 hits in 892 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="IRF1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="IRF1"/>
<dbReference type="GenomeRNAi" id="3659"/>
<dbReference type="Pharos" id="P10914">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P10914"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="RNAct" id="P10914">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000125347">
<property type="expression patterns" value="Expressed in granulocyte and 218 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P10914">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P10914">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000976">
<property type="term" value="F:transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007596">
<property type="term" value="P:blood coagulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043374">
<property type="term" value="P:CD8-positive, alpha-beta T cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007050">
<property type="term" value="P:cell cycle arrest"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035458">
<property type="term" value="P:cellular response to interferon-beta"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071260">
<property type="term" value="P:cellular response to mechanical stimulus"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051607">
<property type="term" value="P:defense response to virus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002376">
<property type="term" value="P:immune system process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0060333">
<property type="term" value="P:interferon-gamma-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045590">
<property type="term" value="P:negative regulation of regulatory T cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032728">
<property type="term" value="P:positive regulation of interferon-beta production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032735">
<property type="term" value="P:positive regulation of interleukin-12 production"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032481">
<property type="term" value="P:positive regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002819">
<property type="term" value="P:regulation of adaptive immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000564">
<property type="term" value="P:regulation of CD8-positive, alpha-beta T cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051726">
<property type="term" value="P:regulation of cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045088">
<property type="term" value="P:regulation of innate immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034124">
<property type="term" value="P:regulation of MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060337">
<property type="term" value="P:type I interferon signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="CDD" id="cd00103">
<property type="entry name" value="IRF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR019817">
<property type="entry name" value="Interferon_reg_fac_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001346">
<property type="entry name" value="Interferon_reg_fact_DNA-bd_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR031215">
<property type="entry name" value="IRF1"/>
</dbReference>
<dbReference type="InterPro" id="IPR017431">
<property type="entry name" value="IRF1/IRF2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036388">
<property type="entry name" value="WH-like_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036390">
<property type="entry name" value="WH_DNA-bd_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11949">
<property type="entry name" value="PTHR11949"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11949:SF3">
<property type="entry name" value="PTHR11949:SF3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00605">
<property type="entry name" value="IRF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF038196">
<property type="entry name" value="IFN_RF1/2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00267">
<property type="entry name" value="INTFRNREGFCT"/>
</dbReference>
<dbReference type="SMART" id="SM00348">
<property type="entry name" value="IRF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF46785">
<property type="entry name" value="SSF46785"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00601">
<property type="entry name" value="IRF_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51507">
<property type="entry name" value="IRF_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0051">Antiviral defense</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Interferon regulatory factor 1" id="PRO_0000154545">
<location>
<begin position="1"/>
<end position="325"/>
</location>
</feature>
<feature type="DNA-binding region" description="IRF tryptophan pentad repeat" evidence="2">
<location>
<begin position="5"/>
<end position="113"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="16">
<location>
<position position="78"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)">
<location>
<position position="275"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)">
<location>
<position position="299"/>
</location>
</feature>
<feature type="sequence variant" description="In GASC; somatic mutation; produces a protein with markedly reduced transcriptional activity but unaltered DNA-binding activity; dbSNP:rs121912469." id="VAR_065134" evidence="18">
<original>M</original>
<variation>L</variation>
<location>
<position position="8"/>
</location>
</feature>
<feature type="sequence variant" description="In GASC; the mutation abolishes DNA binding and transactivating activities; dbSNP:rs121912470." id="VAR_065135" evidence="4">
<original>W</original>
<variation>R</variation>
<location>
<position position="11"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of acetylation. Partial loss of DNA-binding and transcriptional activity." evidence="16">
<original>K</original>
<variation>R</variation>
<location>
<position position="78"/>
</location>
</feature>
<feature type="mutagenesis site" description="Some loss of sumoylation. Partial inhibition of acetylation and activity. Abolishes sumoylation, diminished ubiquitination, higher resistance to degradation, and increased apoptotic activity; when associated with R-299." evidence="8">
<original>K</original>
<variation>R</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="mutagenesis site" description="Large loss of sumoylation. Abolishes sumoylation, diminished ubiquitination, higher resistance to degradation, and increased apoptotic activity; when associated with R-275." evidence="8">
<original>K</original>
<variation>R</variation>
<location>
<position position="299"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; no nucleotide entry and 2; no nucleotide entry." ref="1 2" evidence="24">
<original>R</original>
<variation>W</variation>
<location>
<position position="5"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; no nucleotide entry and 2; no nucleotide entry." ref="1 2" evidence="24">
<original>FQ</original>
<variation>LE</variation>
<location>
<begin position="34"/>
<end position="35"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; no nucleotide entry and 2; no nucleotide entry." ref="1 2" evidence="24">
<original>T</original>
<variation>I</variation>
<location>
<position position="220"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P15314"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00840"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10094406"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10395927"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15226432"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15509808"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17516545"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17942705"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18084608"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18497060"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18641303"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19404407"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19851330"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21389130"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22200613"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22367195"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="32385160"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9679752"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11244049"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11846971"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11846974"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="16932750"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="20049431"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000305"/>
<sequence length="325" mass="36502" checksum="2E06245A212D1541" modified="2002-04-16" version="2">MPITRMRMRPWLEMQINSNQIPGLIWINKEEMIFQIPWKHAAKHGWDINKDACLFRSWAIHTGRYKAGEKEPDPKTWKANFRCAMNSLPDIEEVKDQSRNKGSSAVRVYRMLPPLTKNQRKERKSKSSRDAKSKAKRKSCGDSSPDTFSDGLSSSTLPDDHSSYTVPGYMQDLEVEQALTPALSPCAVSSTLPDWHIPVEVVPDSTSDLYNFQVSPMPSTSEATTDEDEEGKLPEDIMKLLEQSEWQPTNVDGKGYLLNEPGVQPTSVYGDFSCKEEPEIDSPGGDIGLSLQRVFTDLKNMDATWLDSLLTPVRLPSIQAIPCAP</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

